AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2658673
Drug: Intravenous analgosedation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous analgosedation with midazolam (0.1 mg/kg) and fentanyl (2 micrograms/kg)
Trial: 21939716
Drug: Vi polysaccharide
RxNorm normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vi polysaccharide vaccine
Trial: 26352252
Drug: 30-gauge needle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-gauge needle for facial injections
Trial: 21483004
Drug: docetaxel plus
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: docetaxel plus high-dose calcitriol (DN-101)
Trial: 17723081
Drug: Dose-separated ferrous
RxNorm normalized name: Ferrous Fumarate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dose-separated ferrous sulfate with MMF (days 9 to 16)
Trial: 17723081
Drug: Polysaccharide iron
RxNorm normalized name: Polysaccharide Iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polysaccharide iron complex administered 2 hours after MMF (days 9 to 16)
Trial: 10589629
Drug: 3.75 mg/mL
RxNorm normalized name: threonine 3.75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg/mL ropivacaine
Trial: 10589629
Drug: 7.5 mg/mL
RxNorm normalized name: pectin 7.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg/mL ropivacaine
Trial: 8933852
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion of alfentanil (0.75 mg bolus followed by 0.36 mg/h for 24 h)
Trial: 8933852
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of alfentanil (0.36 mg/h for 24 h)
Trial: 1680361
Drug: Fentanyl 7
RxNorm normalized name: FENTANYL 75MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 7 micrograms kg‐1 followed by infusion of 3 micrograms kg‐1 h‐1
Trial: 24218528
Drug: Rivastigmine (transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivastigmine (transdermal patch of 9.5 mg/day)
Trial: 20538557
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg sibutramine once daily for 19 months
Trial: 20538557
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg sibutramine once daily for 19 months
Trial: 16291416
Drug: BIAsp 30
RxNorm normalized name: Fiasp
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: BIAsp 30 monotherapy
Trial: 10498359
Drug: Topical and
RxNorm normalized name: norgestimate and ethinylestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical and subcutaneous epinephrine with bovine topical thrombin (1000 U/ml)
Trial: 10498359
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no epinephrine, only bovine topical thrombin)
Trial: 28266591
Drug: Aggressive hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive hydration (20 ml/kg bolus followed by 3 ml/kg/h)
Trial: 28266591
Drug: Standard hydration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard hydration (10 ml/kg bolus followed by 1.5 ml/kg/h)
Trial: 25864739
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (rhGH) at 0.067 mg/kg/day
Trial: 24007461
Drug: Group 2
RxNorm normalized name: Chlamydophila psittaci biogroup 2 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2 (from <5 mg/L to ≥5 mg/L, n = 45)
Trial: 24007461
Drug: Group 4
RxNorm normalized name: Chlamydophila psittaci biogroup 4 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 4 (from ≥5 mg/L to ≥5 mg/L, n = 80)
Trial: 12875938
Drug: Intrarectal lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrarectal lidocaine gel (10 cc of 2% lidocaine gel)
Trial: 12875938
Drug: Periprostatic nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periprostatic nerve block (10 cc of 1% lidocaine solution injected under ultrasound guidance)
Trial: 9344323
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with DOX/DDP
Trial: 9344323
Drug: Histological response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Histological response to neoadjuvant chemotherapy
Trial: 9344323
Drug: Change of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Change of chemotherapy for poor histological response
Trial: 9344323
Drug: Increased dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dose intensity with G-CSF
Trial: 9344323
Drug: Incorporation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incorporation of new agents like Ifosfamide
Trial: 9344323
Drug: Various drug
RxNorm normalized name: VARIOUS DRUG CLASSES IN ATC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various drug administration methods
Trial: 1314711
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of trivalent oral poliovirus vaccine (TOPV) at birth and subsequent doses at 2, 4, and 9 months of age (Group A)
Trial: 1314711
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of trivalent oral poliovirus vaccine (TOPV) at 2, 4, and 6 months of age (Group B)
Trial: 25900227
Drug: Remifentanil 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 0.1 μg/kg/min infusion
Trial: 25900227
Drug: Remifentanil 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 0.3 μg/kg/min infusion
Trial: 21124330
Drug: Amlodipine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (2.5 mg/day increased to 10 mg/day)
Trial: 20008241
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cyclophosphamide, thalidomide, and dexamethasone
Trial: 20008241
Drug: Standard MPT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard MPT or MPV with reduced doses
Trial: 20008241
Drug: Accurate management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accurate management of treatment-related adverse events
Trial: 17996133
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy for coronary heart disease (Control)
Trial: 15485433
Drug: Open irrigated‐tip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open irrigated‐tip catheter (group B, 65 degrees C, 50 W, 60 s, 17 mL/min flow)
Trial: 9704873
Drug: moclobemide (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moclobemide (450 mg/day)
Trial: 9704873
Drug: clomipramine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clomipramine (150 mg/day)
Trial: 82680
Drug: Cimetidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1 g/day) for 3, 6, 9, or 12 months
Trial: 82680
Drug: Cimetidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1 g/day) for 1 year
Trial: 27922948
Drug: 24-hour morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour morphine use
Trial: 23233710
Drug: CHOP chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHOP chemotherapy plus iodine-131 tositumomab (CHOP-RIT)
Trial: 20141067
Drug: Local diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local diltiazem ointment (group D)
Trial: 20141067
Drug: Local glyceryl
RxNorm normalized name: glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local glyceryl trinitrate ointment (group GTN)
Trial: 20141067
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of botulinum toxin (group BT)
Trial: 12945826
Drug: Analysis of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analysis of nutrients (e.g., vitamin C, vitamin A, cholesterol)
Trial: 10532600
Drug: RBC transfusions
RxNorm normalized name: Ultratag RBC KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RBC transfusions if Hb < 8 g/dL or predetermined clinical conditions
Trial: 10532600
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treated according to physician's orders (Hb < 9 g/dL)
Trial: 7080769
Drug: Inactivated chromatographic
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated chromatographic influenza vaccine A(H3N2)
Trial: 24767719
Drug: 6-day course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-day course of daily prednisolone therapy during an upper respiratory tract infection (URTI)
Trial: 24767719
Drug: No change
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No change to current therapy (placebo)
Trial: 15783019
Drug: Dai-kenchu-to (DKT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dai-kenchu-to (DKT) 5g administered orally three times a day
Trial: 15783019
Drug: Lactulose 16g
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lactulose 16g administered orally three times a day
Trial: 10532092
Drug: Aminoglutethimide (AG)
RxNorm normalized name: Aminoglutethimide
DrugBank: Aminoglutethimide (DB00357)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aminoglutethimide (AG) 250 mg twice daily with corticosteroid support
Trial: 8530996
Drug: Oral anticoagulation
RxNorm normalized name: monitoring agent for oral anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulation not modified and local tranexamic acid applied during and after surgery
Trial: 8530996
Drug: Oral anticoagulation
RxNorm normalized name: monitoring agent for oral anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulation reduced and calcium heparin added preoperatively
Trial: 7113711
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg (D)
Trial: 7113711
Drug: Alcohol 0.5
RxNorm normalized name: isopropyl alcohol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol 0.5 g/kg (A)
Trial: 7113711
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg (D) + Alcohol 0.5 g/kg (A)
Trial: 27903924
Drug: Cabazitaxel (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabazitaxel (20 mg/m2, increased to 25 mg/m2 for subsequent cycles if tolerated)
Trial: 16205597
Drug: Dose dense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose dense chemotherapy incorporating AC and paclitaxel
Trial: 8901799
Drug: Sour milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sour milk (Calpis), 95 mL daily for 8 weeks
Trial: 8901799
Drug: Placebo (artificially
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (artificially acidified milk), 95 mL daily for 8 weeks
Trial: 6848468
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (n = 50)
Trial: 26541103
Drug: Central air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Central air injection
Trial: 26541103
Drug: Peripheral air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral air injection
Trial: 23453547
Drug: Early enteral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early enteral fat supplement and fish oil
Trial: 17698733
Drug: cTnT assay
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cTnT assay (detection limit < or = 0.01 ng/mL)
Trial: 17698733
Drug: hsTnT assay
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hsTnT assay (detection limit < or = 0.001 ng/mL)
Trial: 12192353
Drug: Ibuprofen syrup
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen syrup (10 mg/kg 3 times a day for 5 days)
Trial: 10665199
Drug: Intra‐oral fluoride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra‐oral fluoride releasing device (IFRD) releasing 0.04 mg/day of fluoride for 12 months
Trial: 2566250
Drug: Midazolam (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.25 mg kg‐1)
Trial: 2566250
Drug: Thiopentone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone (5 mg kg‐1)
Trial: 998556
Drug: Raw wheat
RxNorm normalized name: Potassium/Wheat Germ 250 MG Oral Powder [NATURFRESH RAW WHEAT GERM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raw wheat bran 12 g/day
Trial: 998556
Drug: Raw wheat
RxNorm normalized name: Potassium/Wheat Germ 250 MG Oral Powder [NATURFRESH RAW WHEAT GERM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raw wheat bran 20 g/day
Trial: 998556
Drug: Cooked bran
RxNorm normalized name: bran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooked bran 13.2 g/day
Trial: 998556
Drug: Cooked bran
RxNorm normalized name: bran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooked bran 22 g/day
Trial: 31601496
Drug: Durvalumab (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Durvalumab (10 mg/kg intravenous, administered 1-42 days after chemoradiotherapy, then every 2 weeks up to 12 months)
Trial: 31601496
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching placebo administered 1-42 days after chemoradiotherapy, then every 2 weeks up to 12 months)
Trial: 17203750
Drug: HAI plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAI plus systemic chemotherapy (HAI+SYC)
Trial: 14622075
Drug: Cognitive‐behavioral analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioral analysis system of psychotherapy (CBASP) with medication
Trial: 8958493
Drug: Ketamine 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 3 mg kg‐1
Trial: 8958493
Drug: Ketamine 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 6 mg kg‐1
Trial: 8958493
Drug: Placebo (cola
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (cola 0.2 mL kg‐1)
Trial: 3293643
Drug: diamorphine in
RxNorm normalized name: Product containing diamorphine in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diamorphine in 0.9% saline (0.5 mg in 15 ml)
Trial: 3293643
Drug: diamorphine mixed
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diamorphine mixed with 0.125% bupivacaine (0.5 mg in 15 ml)
Trial: 29348380
Drug: Nigella sativa
RxNorm normalized name: NIGELLA SATIVA SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nigella sativa seed extract 300 mg twice daily for 28 days
Trial: 21849027
Drug: Brief Intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Intervention (BI) combined with treatment as usual
Trial: 19022547
Drug: Standard multivitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard multivitamin containing high doses of folic acid and vitamins B(6) and B(12)
Trial: 17252186
Drug: Two cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two cycles of 'eight-drugs-in-one-day' (8-in-1) chemotherapy followed by involved-field radiotherapy and six cycles of 8-in-1 chemotherapy
Trial: 12808771
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration solution
Trial: 1732770
Drug: Nonionic, low-osmolality
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonionic, low-osmolality radiocontrast agents
Trial: 1732770
Drug: Ionic, high-osmolality
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ionic, high-osmolality radiocontrast agents
Trial: 31436835
Drug: Edoxaban 60
RxNorm normalized name: edoxaban 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 60 mg once daily (QD)
Trial: 26915483
Drug: CUR 320
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CUR 320 mg/day
Trial: 17289537
Drug: Darbepoetin alfa
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Darbepoetin alfa administered once monthly
Trial: 9663889
Drug: Mupirocin ointment
RxNorm normalized name: Mupirocin Ointment
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin ointment applied at the catheter exit site (daily or three times per week)
Trial: 9663889
Drug: Mupirocin ointment
RxNorm normalized name: Mupirocin Ointment
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin ointment applied at the catheter exit site
Trial: 2495214
Drug: Lactose-free pelletized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactose-free pelletized sodium cromoglycate (20 mg)
Trial: 2495214
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate plus lactose (20 mg)
Trial: 841307
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg cocaine hydrochloride intranasally
Trial: 841307
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg cocaine hydrochloride intranasally
Trial: 841307
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg cocaine hydrochloride intranasally
Trial: 841307
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg cocaine hydrochloride intravenously
Trial: 841307
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg cocaine hydrochloride intravenously
Trial: 29937865
Drug: ART/TB treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ART/TB treatment arm
Trial: 29937865
Drug: TB alone
RxNorm normalized name: dextroamphetamine
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TB alone treatment arm
Trial: 23690688
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment alone
Trial: 23690688
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of antihypertensive treatment with effective CPAP
Trial: 23690688
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment with effective CPAP
Trial: 21950232
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml of 2% Lidocaine Hydrochloride into the fracture hematoma (Group B)
Trial: 19801055
Drug: Time Pressure
RxNorm normalized name: Sudafed PE Sinus Daytime Pressure + Pain + Cough Solution (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time Pressure Management (TPM) strategy, 10 hours of treatment
Trial: 3316296
Drug: Chlorhexidine acetate
RxNorm normalized name: Chlorhexidine Acetate
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine acetate chewing gum (5 mg per piece)
Trial: 3316296
Drug: Chlorhexidine acetate
RxNorm normalized name: Chlorhexidine Acetate
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine acetate chewing gum with hydrogen peroxide releasing agent
Trial: 3316296
Drug: Control gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control gum (gum base with flavoring agents, no CHX or H2O2)
Trial: 26044391
Drug: Lysine-derived urethane
RxNorm normalized name: Urethane
DrugBank: Urethane (DB04827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lysine-derived urethane adhesive (Treatment group)
Trial: 15984585
Drug: Conventional mono
RxNorm normalized name: tiotropium bromide mono
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional mono mac therapy (20 mg twice a day)
Trial: 15984585
Drug: Mono mac
RxNorm normalized name: tiotropium bromide mono
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mono mac chronotherapy (10 to 20 mg 30 minutes before PMI episodes)
Trial: 12610046
Drug: GLP-1 at
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 at a dose of 1.5 pmol.kg(‐1)x min(‐1)
Trial: 10496529
Drug: MSI-L gastric
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSI-L gastric adenomas
Trial: 10496529
Drug: MSI-L gastric
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSI-L gastric carcinomas
Trial: 10496529
Drug: MSI-L tumors
RxNorm normalized name: human breast tumor cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MSI-L tumors
Trial: 8621746
Drug: Fenfluramine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine (60 mg oral dose)